Diligence memo · auto-generated · as of July 2, 2026

Archimedes Innovations, PBC

Archimedes Innovations, PBC looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Archimedes Innovations, PBC operates in Other Technology, based in ANN ARBOR.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Archimedes Innovations, PBC has raised $828K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $440K on 2020-12-11.

Most recent recorded round closed around 2020-12-11.

Valuation (modeled)modeled

Provath models Archimedes Innovations, PBC at approximately $15M (range $287K–$145M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 1.34× the median modeled value of Pre-Seed Other Technology companies in 2019–2021 (1021 peers) — value vs value, same stage and era. Within the normal band (134% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 4 months.

Last raise 5.6 yr ago; this sector typically re-raises about every 13 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 1.1× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 25% of Other Technology peers (21302 compared).

Modeled value ranks above 30% of those peers.

Closest niche peers: Rabbit Inc., Pegasystems Inc, Vitally, Inc., Zurra, Inc., HR Soft Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.